VarroMed

RSS

oxalic acid dihydrate / formic acid

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for VarroMed.It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use VarroMed.

For practical information about using VarroMed, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 24/08/2018

Authorisation details

Product details
Name
VarroMed
Agency product number
EMEA/V/C/002723
Active substance
  • oxalic acid dihydrate
  • formic acid
International non-proprietary name (INN) or common name
oxalic acid dihydrate / formic acid
Species
Bees
Anatomical therapeutic chemical veterinary (ATCvet) codes
QP53AG30
Publication details
Marketing-authorisation holder
BeeVital GmbH
Revision
1
Date of issue of marketing authorisation valid throughout the European Union
02/02/2017
Contact address
Wiesenbergstrasse
5164 Seeham
Austria

Product information

17/08/2018 VarroMed - EMEA/V/C/002723 - IAIN/0001/G

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Ectoparasiticides for topical use
  • including insecticides
  • Organic acids
  • combinations

Therapeutic indication

Treatment of varroosis (Varroa destructor) in honey bee colonies with and without brood

Assessment history

How useful was this page?

Add your rating